DOI:
10.1055/s-00023610
Drug Research
LinksClose Window
References
Alexander T, Sarfert R, Klotsche J et al.
The proteasome inhibitior bortezomib depletes plasma cells and ameliorates clinical manifestations of refractory systemic lupus erythematosus.
Ann Rheum Dis 2015;
74: 1474-1478
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.